Apollo Hospitals demonstrates strong investment potential through broad-based Q4 FY26 growth across hospitals, diagnostics, pharmacy, and digital healthcare, driven by the Apollo Health and Lifestyle segment's rapid diagnostics network expansion and improving operating efficiency, combined with a proposed merger of Apollo Cradle and Apollo Fertility with Cloudnine Hospitals expected by Q2 FY27, and aggressive capacity expansion plans to increase hospital beds from 9,600 to 13,000, supported by a valuation of approximately 26 times FY27 estimated EBITDA.
Deep Dive
Prerequisite Knowledge
- No data available.
Where to go next
- No data available.
Deep Dive
Moneycontrol Ideas For Profit: Apollo Hospitals | CNBC TV18
Added:Let's get you some ideas for profit.
Today we do have our colleague from Moneycontrol Pro, Lekha Bhatlani Jamnani, who's joining in with a stock.
>> Uh yes, thanks. So my stock pick is Apollo Hospitals, which delivered a strong Q4 FY26 performance, wherein growth was broad-based across hospitals, diagnostics, pharmacy, and digital healthcare. Our key growth driver is the Apollo Health and Lifestyle business.
Now this segment is witnessing strong momentum supported by rapid expansion of its diagnostics network, improving operating efficiency, and the strengthening network economics. Now as scale increases, this segment is expected to contribute meaningfully to both growth and profitability.
Another important catalyst is the proposed merger of the Apollo Cradle and Apollo Fertility with Cloudnine Hospitals, expected to be completed by Q2 FY27. The transaction unlocks significant value for shareholders while enabling Apollo to retain participation in the future growth of what will become one of India's largest integrated maternity and fertility care platforms.
Apollo also offers strong long-term growth visibility through its aggressive capacity expansion plans. The management aims to increase the hospital capacity to around 13,000 beds from the current 9,600 beds over the medium term.
Now looking ahead, capacity additions in the hospitals business are expected to support sustained revenue growth while improving profitability in Apollo 24/7 and diagnostics should drive margin expansion.
The Cloudnine transaction further demonstrates management's ability to unlock value from its healthcare portfolio.
At current valuation of around 26 times FY27 estimated EBITDA, Apollo remains one of the highest quality healthcare compounders in India with multiple drivers for long-term value creation.
>> Always good to see you, Lekha. Thanks a lot for joining in and educating us about that particular name. For >> Oh.
Related Videos
Best SpaceX Partner To Buy Now | These Could Skyrocket 10x
wisetInvestor
141 views•2026-06-18
How To Make Your Trading Losses Smaller
AxiaFutures
115 views•2026-06-18
W.I.N.N.E.R....DEAL or NO DEAL....CASHWORD BONUS....GRID OF FORTUNE SCRATCHCARDS
georgegrimwood1305
627 views•2026-06-18
50+ Items I Bought Online To Sell On Vinted & Ebay As A Six Figure Reseller
Sellingwithsully
719 views•2026-06-18
5 Reasons why i'll BUY family bank shares
goodjoseph220
5K views•2026-06-18
The Easiest Way to Understand Bullish vs Bearish
TradeCraftInvesting
316 views•2026-06-14
Most People Will Miss This Again. SCHD Investors Won't. (2026 Warning)
InvestEdYT
241 views•2026-06-14
From a Concrete Slab to This | The Royalty Auto Service Story
theroyaltyautoservice
37K views•2026-06-14











